Michael R Jaff Selected Research

Postthrombotic Syndrome

1/2021	Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.
10/2019	Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.
1/2019	Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis.
4/2013	Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael R Jaff Research Topics

Disease

38	Peripheral Arterial Disease 01/2022 - 11/2002
19	Thrombosis (Thrombus) 01/2021 - 01/2002
16	Intermittent Claudication 11/2019 - 11/2002
16	Stroke (Strokes) 01/2019 - 10/2004
14	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2002
14	Chronic Limb-Threatening Ischemia 08/2020 - 07/2009
14	Pathologic Constriction (Stenosis) 06/2019 - 09/2004
12	Pulmonary Embolism 01/2022 - 06/2004
12	Hemorrhage 01/2022 - 01/2002
9	Pain (Aches) 11/2019 - 08/2013
8	Renal Artery Obstruction (Renal Artery Stenosis) 01/2019 - 09/2005
8	Carotid Stenosis (Carotid Artery Stenosis) 01/2018 - 10/2004
7	Atherosclerosis 07/2020 - 03/2008
6	Venous Thromboembolism 01/2022 - 01/2002
6	Myocardial Infarction 06/2019 - 11/2011
6	Ischemia 01/2017 - 09/2004
5	Hypertension (High Blood Pressure) 07/2014 - 09/2005
4	Postthrombotic Syndrome 01/2021 - 04/2013
4	Carotid Artery Diseases 01/2014 - 10/2004
3	Neoplasms (Cancer) 01/2017 - 11/2011
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2015 - 01/2002
3	Chronic Renal Insufficiency 09/2014 - 01/2014
2	Venous Insufficiency 01/2021 - 01/2019
2	Amaurosis Fugax 03/2016 - 05/2013
2	Hypotension (Low Blood Pressure) 08/2015 - 06/2015
2	Right Ventricular Dysfunction 06/2015 - 06/2014
2	Renovascular Hypertension (Goldblatt Syndrome) 12/2014 - 03/2014
2	Heart Failure 01/2014 - 06/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2013 - 08/2009
2	Ischemic Stroke 01/2012 - 09/2007
2	Wounds and Injuries (Trauma) 11/2011 - 12/2010
1	Fibrosis (Cirrhosis) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 10/2020
1	Inflammation (Inflammations) 07/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2019
1	Narcolepsy 02/2019
1	Ulcer 01/2018
1	Gangrene 01/2018
1	Disease Progression 06/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 06/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Transient Ischemic Attack 03/2016
1	Lymphedema (Milroy Disease) 12/2015
1	Vascular Diseases (Vascular Disease) 10/2015
1	Hematoma 08/2015
1	Pulmonary Hypertension 08/2015
1	Critical Illness (Critically Ill) 08/2015

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 07/2020 - 05/2014
11	nitinolIBA 09/2018 - 12/2006
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 10/2011
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2002
4	AnticoagulantsIBA 12/2017 - 01/2002
4	Phenobarbital (Luminal)FDA Link 10/2015 - 10/2004
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2017 - 08/2009
3	MetalsIBA 06/2017 - 10/2011
3	Antihypertensive Agents (Antihypertensives)IBA 01/2014 - 03/2008
3	LipidsIBA 03/2010 - 03/2008
2	Streptokinase FDA Link 01/2019 - 08/2015
2	Dihydrotachysterol (AT 10)IBA 01/2019 - 08/2014
2	Biomarkers (Surrogate Marker)IBA 06/2015 - 08/2011
2	FibrinIBA 01/2015 - 01/2002
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2015 - 01/2002
2	Pancreatic Elastase (Elastase)IBA 09/2014 - 08/2014
2	Warfarin (Coumadin)FDA LinkGeneric 07/2009 - 06/2004
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	salicylhydroxamic acid (SHAM)IBA 07/2020
1	Central Nervous System StimulantsIBA 02/2019
1	Amphetamine (Amfetamine)FDA LinkGeneric 02/2019
1	B 31IBA 01/2019
1	C 76 (C76)IBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	dimemorfan (AT 17)IBA 01/2017
1	P 829IBA 02/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2015
1	TroponinIBA 06/2015
1	Natriuretic PeptidesIBA 06/2015
1	Aluminum Oxide (Sapphire)IBA 03/2015
1	AngiotensinsIBA 12/2014

Therapy/Procedure

48	Therapeutics 01/2022 - 01/2002
31	Stents 10/2020 - 09/2004
19	Surgical Amputation (Amputations) 01/2022 - 07/2009
16	Catheters 01/2022 - 12/2009
8	Carotid Endarterectomy 01/2018 - 10/2004
7	Vena Cava Filters (Inferior Vena Cava Filter) 01/2022 - 06/2005
7	Vascular Surgical Procedures 03/2012 - 12/2010
5	Embolic Protection Devices 05/2017 - 10/2004
4	Thrombolytic Therapy 01/2020 - 06/2004
4	Contraindications 01/2017 - 06/2005
4	Secondary Prevention 01/2012 - 03/2008
3	Drug Therapy (Chemotherapy) 06/2017 - 11/2002
3	Endarterectomy (Thromboendarterectomy) 05/2017 - 10/2004
2	Limb Salvage 08/2020 - 10/2014
2	Embolectomy 12/2018 - 06/2015
2	Compression Stockings 12/2015 - 04/2013
2	Drug-Eluting Stents 10/2014 - 10/2011
2	Prostheses and Implants (Prosthesis) 08/2013 - 11/2012
2	Exercise Therapy (Therapy, Exercise) 07/2009 - 11/2002
1	Aftercare (After-Treatment) 10/2018
1	Percutaneous Coronary Intervention 06/2017
1	Thrombectomy 08/2015